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A WNT/b-CATENIN NEGATIVE FEEDBACK LOOP INHIBITS IL-1b
INDUCED MMP EXPRESSION IN HUMAN ARTICULAR CHONDROCYTES
B. Ma, C.A. van Blitterswijk, M. Karperien. Univ. of Twente, Enschede,
Netherlands
Purpose: Recent animal studies suggest that activation of Wnt/b-catenin
signaling in articular chondrocytes might be a driving factor in the path-
ogenesis of osteoarthritis (OA) by stimulating amongst others the
expression of matrix metalloproteinases (MMPs). Indeed in animal chon-
drocytes IL-1b induced MMP expression is mediated by activation of
canonical Wnt/b-catenin signaling. This study aimed to investigate the role
of Wnt/b-catenin signaling in IL-1b induced MMP expression in human
chondrocytes.
Methods: Primary cultures of human articular chondrocytes derived from
post mortem healthy donors or patients with end stage osteoarthritis or
rheumatoid arthritis were used in all experiments. Cells were stimulated
with recombinant growth factors and cytokines. Changes in gene and
protein expression were studied using qPCR, Western blot, and enzymatic
essays. Multiple strategies for activation and inhibition of signaling path-
ways in human chondrocytes, such as lentiviral mediated gene over-
expression or gene knock down were used. Luciferase reporter assays and
co-immunoprecipitation essays were used to study the interaction
between b-catenin and NF-kB.
Results: IL-1b potently stimulated MMP1, -3 and -13 expression in
human and murine chondrocytes dose-dependently. In marked contrast,
co-stimulation with the recombinant Wnt3A, which activates canonical
Wnt/b-catenin signaling, potently inhibited IL-1b induced MMP dose-
dependently in human chondrocytes but not in murine chondrocytes.
This inhibitory effect was found in human chondrocytes irrespective of
the disease state of the donor being either healthy, osteoarthritic or
rheumatoid arthritic and was also found in human bone marrow derived
mesenchymal stem cells. In contrast, Wnt/b-catenin signaling induced
MMP expression in chondrocytes of all animal species tested, revealing
an unprecedented species difference. Wnt3A's inhibitory effect was
found in both basal conditions and after IL-1b stimulation at the mRNA
level, protein level and in enzymatic essays. Wesetern blot indicated that
IL-1b indirectly activated b-catenin in human chondrocytes. This was
due to IL-1b induced upregulation of the canonical Wnt7B and down
regulation of the Wnt-signaling antagonists DKK1, Wif1 and FRZb as
demonstrated by gene knock down and gene overexpression studies. The
inhibitory effect of Wnt3A on IL-1b induced MMP expression was
independent of TCF/LEF transcription factors, since knock down of TCF4
did not alter Wnt3A's effect. This was in marked contrast to murine
chondrocytes in which knock down of TCF4 completely blocked IL-1b
induced MMP expression. Subsequently, we showed that the inhibitory
effect on IL-1b induced MMP expression in human chondrocytes was
due to an inhibitory protein-protein interaction between b-catenin and
NF-kB/p65RELA blocking the activation of NF-kB promoter reporter
constructs as well as inhibiting the expression of established NF-kB
target genes like IL-6.
Conclusions: Our study reveals an unexpected and unprecedented
species difference between human and animal chondrocytes with respect
of the role of Wnt/b-catenin signaling in the regulation of MMP expres-
sion. In marked contrast to mouse chondrocytes in which Wnt/b-catenin
signaling is part of an IL-1b activated pro-catabolic sequence resulting in
increased MMP expression, in human cells b-catenin has an unexpected
anti-catabolic role. We provide evidence that Wnt/b-catenin signaling is
part of an IL-1b activated negative feedback loop involving upregulation
of the canonical Wnt7B and down regulation of established Wnt-antag-
onists like DKK1. This leads to activation of b-catenin, which in turn
inhibits NF-kB activity due to an inhibitory protein-protein interaction
with p65RELA. Our results question the relevance of animal models for
studying the role of Wnt/b-catenin signaling in osteoarthritis. They
furthermore imply that upregulated b-catenin in human osteoarthritic
cartilage may be part of an anti-catabolic response counteracting pro-
catabolic NF-kB signaling.256
BMP-9 INDUCES BOTH SMAD1/5/8 AND SMAD2/3 PHOSPHORYLATION,
AND SPECIFIC RESPONSE GENES, IN CHONDROCYTES
A. van Caam, E. Blaney Davidson, E. Vitters, W. van den Berg, P. van der
Kraan. Radboud Univ. Nijmegen Med. Ctr., Nijmegen, Netherlands
Background: Osteoarthritis is characterized by loss of articular cartilage.
The main cartilage degrading enzyme is Matrix metalloproteinase 13
(MMP13). Expression of MMP13 is positively correlated with Activin
receptor-like kinase 1 (ALK1) expression. Moreover, terminal differentia-
tion of chondrocytes is induced by ALK1 via phosphorylation of Smad1/5/8
(Smad1/5/8p). BMP-9, also known as GDF-2, has recently been character-
ized as a potent, high-afﬁnity ALK1 ligand, that is present in serum in high
amounts . We wanted to further investigate intracellular BMP-9 signaling
in chondrocytes to clarify its role in cartilage maintenance and
degradation.
Purpose: To study Smad1/5/8 and Smad2/3 phosphorylation kinetics in
response to addition of exogenous BMP-9, to investigate BMP-9’s potency
on chondrocytes, and to investigate downstream signaling responses on
mRNA level.
Methods: Both primary bovine chondrocytes, isolated from the meta-
carpophalangeal joint of 2 year old animals, as well as the murine H4
chondrocyte cell line were used in this study. Chondrocytes were cultured
to near conﬂuency, and subsequently incubated with BMP-9. After short
term stimulation (1 h), Smad phosphorylation was analyzed by speciﬁc
Smad2/3p and Smad1/5/8p staining of Western blots. After long term
stimulation (24-48 h), expression of PAI-1, a downstream marker of
Smad2/3 signaling, and ID-1, a downstream marker of Smad1/5/8
signaling, were analyzed by quantitative real time PCR (qPCR).
Results: In both the murine cell line, as well as the primary bovine
chondrocytes, addition of BMP-9 resulted in phosphorylation of Smad 1/5/
8, that was maximal at very low concentrations (100 pg / ml). Unexpect-
edly, Smad2/3p was also observed at this concentration. Further investi-
gations showed that BMP-9-induced Smad2/3p was maximal after 1 h, at
the physiological relevant concentration of 5 ng/ml. Exposure of chon-
drocytes to BMP9 not only resulted in both Smad1/5/8p and Smad2/3p but
also in transcription of pathway speciﬁc response genes, as observed by
a signiﬁcant increase in PAI-1 and ID-1 mRNA levels after both 24 and 48h.
In both cell types, collagen type 2A1 and aggrecan mRNA levels were also
up regulated by BMP9. In the described experiments, no signiﬁcant
changes in MMP13 expression were observed after 48 h of BMP-9
stimulation.
Conclusion: In chondrocytes, BMP9 is capable of inducing both Smad1/5/
8p and Smad2/3p. By doing so it can up regulate both PAI-1 and ID-1
simultaneously. BMP-9 is very potent in inducing Smad phosphorylation,
as very low concentrations (pg/ml) are sufﬁcient for signal induction. The
induction of Smad2/3p and subsequent PAI-1 activity sets BMP-9 apart
from other BMPs, like BMP-2 and BMP-6, that only induce Smad1/5/8
phosphorylation. The lack of MMP13 expression after BMP-9 stimulation
can be explained by the induced Smad2/3p expression, as this potently
blocks MMP13 transcription. Based on these results we propose that
exposure of young cartilage to BMP-9 does not result in MMP13 expression
due to its ability to induce Smad2/3p. However, we previously reported
that in ageing cartilage the ability to phosphorylate Smad2/3 is reduced,
and therefore BMP-9 exposure will most likely result in MMP13 produc-
tion in old cartilage.
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A TYPE II COLLAGEN PEPTIDE ACTIVATES P38 MITOGEN-ACTIVATED
PROTEIN KINASE AND ITS INHIBITION BY HYALURONAN VIA ICAM-1
IN ARTICULAR CHONDROCYTES
T. Yasuda. Tenri Univ., Tenri, Japan
Background: Some proteolytic products of cartilage matrix may
contribute to cartilage destruction through their catabolic activities.
Recently, we have found that a 24-mer synthetic peptide of type II collagen
named CB12-II stimulates type II collagen cleavage with induction of
